Oral candidiasis of HIV-infected children undergoing sequential HIV therapies
Open Access
- 1 January 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 47 (2) , 149-156
Abstract
Candida oral flora from 52 Brazilian HIV-infected children was characterized while they received antiviral monotherapy therapy and subsequently, HAART with the use of protease inhibitor. There was a significant increase in non-C. albicans Candida isolates from 9.6–28.8% (P=0.005) after the children were placed on protease inhibitor therapy. Although Candida albicans still remained the most commonly isolated species, relative presence of C. tropicalis (n=9) followed by C. parapsilosis (n=8) markedly increased in association with protease inhibitor therapy. Furthermore, rare Candida species including C. dubliniensis, C. norvegensis, C. humicula and C. rugosa also appeared after the onset of protease inhibitor therapy. Subsequent investigation of the antifungal sensitivity of these diverse isolates, derived during protease inhibitor therapy, demonstrated some variation in antifungal sensitivity. With notable exceptions, the majority were sensitive to amphotericin B while most C. albicans and non-C. albicans Candida isolates were also susceptible to fluconazole, itraconazole and ketoconazole. Amongst exceptions was a single C. tropicalis isolates which was resistant to fluconazole (MIC>64 µl/ml) and one C. albicans-B isolate which showed cross-resistance to all azoles and amphotericin.Keywords
This publication has 39 references indexed in Scilit:
- Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistanceJournal of Hospital Infection, 2002
- The Evolution ofCandidaSpecies and Fluconazole Susceptibility among Oral and Vaginal Isolates Recovered from Human Immunodeficiency Virus (HIV)–Seropositive and At‐Risk HIV‐Seronegative WomenThe Journal of Infectious Diseases, 2001
- In Vitro and In Vivo Anticandidal Activity of Human Immunodeficiency Virus Protease InhibitorsThe Journal of Infectious Diseases, 1999
- Non-albicansoralcandidosis in HIV-positive patientsJournal of Antimicrobial Chemotherapy, 1999
- Persistent oral candidosis by non‐albicans Candida strains including Candida glabrata in a human immunodeficiency virus‐infected patient observed over a period of 6 yearsMycoses, 1998
- National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE ProgramDiagnostic Microbiology and Infectious Disease, 1998
- Mixed oropharyngeal candidiasis due toCandida albicans and non-albicans Candida strains in HIV-infected patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistanceThe American Journal of Medicine, 1996
- Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida speciesJournal of Medical Microbiology, 1996
- Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patientsEuropean Journal of Epidemiology, 1993